HNSCC: Current and Emerging Therapeutic Strategies

Join Aarti Bhatia, MD, MPH, and Deborah J. Wong, MD, PhD. for a discussion on the current and evolving treatment landscape in head and neck squamous cell carcinoma (HNSCC), including IO-based therapy, EGFR-targeted bispecific antibodies, antibody–drug conjugates, HPV-targeted vaccines, and novel radiosensitizers. Explore the latest phase III clinical trial data and emerging treatment sequencing strategies shaping the future of care for HPV-positive and HPV-negative patients with head and neck cancer. Listen now to stay ahead of the latest advances in HNSCC treatment.